WEBINAR SERIES ON-DEMAND: Modern medicines series SGLT2 Inhibitors: What we need to know

Over these 3 programmes, Professor Cliff Bailey and colleagues assessed the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.

At the end of the year the series will complete with 2 further update webinars following EASD, ADA and AHA, dates and times tbc.


 

Programme 1 – Understanding SGLT2 inhibition

Tuesday 9th February, 19.00

Professor Cliff Bailey – Type 2 diabetes and SGLT2 inhibitors in context
Professor Vinod Patel – Managing glycaemic control and body weight

Click below to watch the webinar on-demand.

Watch on-demand now Request a password

This webinar is password protected, you will have received the password in the invitation email. If you don’t have a password please feel free to email us at: admin@issuesandanswers.org.


 

Programme 2 – SGLT2 inhibitors and the heart

Tuesday 23rd February, 19.00

Professor Cliff Bailey – Effects of SGLT2 inhibitors on cardiovascular function
Dr Martin Hadley-Brown – Role of SGLT2 inhibitors in the management of CV disease

Click below to watch the webinar on-demand.

Watch on-demand now Request a password

This webinar is password protected, you will have received the password in the invitation email. If you don’t have a password please feel free to email us at: admin@issuesandanswers.org.


 

Programme 3 – SGLT2 inhibitors and the kidney

Tuesday 9th March, 19.00

Professor Cliff Bailey – Reno-protective effects of SGLT2 inhibitors
Dr Pam Brown – SGLT2 inhibitors in the management diabetic kidney disease

Click below to watch the webinar on-demand.

Watch on-demand now Request a password

This webinar is password protected, you will have received the password in the invitation email. If you don’t have a password please feel free to email us at: admin@issuesandanswers.org.

Don’t forget to share this programme with a colleague click here

This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant

 

 

The content, opinions and statements made in this webinar are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board and no liability is accepted for the consequences of any misleading or inaccurate information. 

Your programme presenters

Professor Cliff Bailey

Emeritus Professor of Clinical Science, Aston University, Birmingham

Professor Vinod Patel

Professor, Diabetes and Clinical Skills,
Warwick Medical School. Honorary
Consultant in Endocrinology and Diabetes, George Eliot Hospital, Nuneaton

Dr Martin Hadley-Brown

FRCGP,
Hughes Hall, University of Cambridge

Dr Pam Brown

GP, SA1 Medical Practice,
Swansea

 


 

Programme 2 – SGLT2 inhibitors and the heart

Tuesday 23rd February, 19.00

Professor Cliff Bailey – Effects of SGLT2 inhibitors on cardiovascular function

Dr Martin Hadley-Brown – Role of SGLT2 inhibitors in the management of CV disease


 

Programme 3 – SGLT2 inhibitors and the kidney

Tuesday 9th March, 19.00

Professor Cliff Bailey – Reno-protective effects of SGLT2 inhibitors

Dr Pam Brown – SGLT2 inhibitors in the management diabetic kidney disease